USING PSA TO ELIMINATE THE STAGING RADIONUCLIDE BONE SCAN
- 1 November 1993
- journal article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 20 (4) , 705-711
- https://doi.org/10.1016/s0094-0143(21)00923-x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Clinical stage Bo or T1c prostate cancer: Nonpalpable disease identified by elevated serum prostate-specific antigen concentrationUrology, 1993
- The TNM classification of prostate cancerThe Prostate, 1992
- Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the ProstateJournal of Urology, 1991
- Predicting Radionuclide Bone Scan Findings in Patients with Newly Diagnosed, Untreated Prostate Cancer: Prostate Specific Antigen is Superior to All Other Clinical ParametersJournal of Urology, 1991
- Evaluating the Use of Mental Health Screening Scales in Primary Care Settings Using Receiver Operating Characteristic CurvesMedical Care, 1987
- Comparison of Enzyme, Clinical, Radiographic, and Radionuclide Methods of Detecting Bone Metastases from Carcinoma of the ProstateRadiology, 1976
- Estimation of Plasma Phosphatase by Determination of Hydrolysed Phenol with Amino-antipyrineJournal of Clinical Pathology, 1954